Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep 4:7:143-51.
doi: 10.2147/RRU.S73566. eCollection 2015.

Optimal management of muscle-invasive bladder cancer - a review

Affiliations
Review

Optimal management of muscle-invasive bladder cancer - a review

Kristen R Scarpato et al. Res Rep Urol. .

Abstract

Muscle-invasive bladder cancer is a complex disease requiring aggressive management. Patients are often older with comorbid conditions that impact treatment options. This review describes the available therapies for invasive urothelial carcinoma, including chemotherapy, radical extirpative surgery, and bladder-preserving strategies.

Keywords: bladder cancer; neoadjuvant chemotherapy; radical cystectomy; urothelial carcinoma.

PubMed Disclaimer

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. - PubMed
    1. Amin MB, McKenney JK, Paner GP, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: pathology. Eur Urol. 2013;63:16–35. - PubMed
    1. Chamie K, Litwin MS. Quality of bladder cancer care in the USA. Expert Rev Pharmacoecon Outcomes Res. 2011;11:619–621. - PubMed
    1. National Comprehensive Cancer Network NCCN Guidelines Version 1.2015. 2015. [Accessed April 30, 2015]. Available from: http://www.nccn.org/professionals/physician_gls/PDF/bladder.pdf.
    1. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–675. - PubMed